Inventor · disambiguated record
Andreas Gschwind
Also filed as: GSCHWIND ANDREAS
5 granted patents·19 pending applications·25 citations·filing 2003–2024
76Inventor score
Files withBOEHRINGER INGELHEIM INT14GSCHWIND ANDREAS5BORGES ERIC1MAX PLANCK GESELLSCHAFT1OTT RENE GEORG1
Top patents by PatentIndex Score
24 records- 0190US11161916B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 2, 2021·4 cites·5 claims
- 0287US9527925B2Bispecific binding molecules binding to VEGF and ANG2GSCHWIND ANDREAS·Filed 2012·Granted Dec 27, 2016·16 cites·24 claims
- 0385US2024141030A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0484US10414828B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2016·Granted Sep 17, 2019·4 cites·13 claims
- 0582US2023203146A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0679US2022363744A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0772US2022017642A1Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0870US2020308267A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 0969US2020207845A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1061US2018201671A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1161US2019135907A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1258US7524495B2Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivationMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Apr 28, 2009·1 cites·7 claims
- 1358US2013259859A1Ang2-binding moleculesOTT RENE GEORG·Filed 2013·Application pending·0 cites
- 1457US2017107281A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1556US8591903B2Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivationULLRICH AXEL·Filed 2009·Granted Nov 26, 2013·0 cites·5 claims
- 1655US2016200806A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1752US2012225081A1Vegf-binding moleculesGSCHWIND ANDREAS·Filed 2011·Application pending·0 cites
- 1847US2014120095A1Bispecific binding molecules for anti-angiogenesis therapyBORGES ERIC·Filed 2013·Application pending·0 cites
- 1942US2011172398A1Bispecific binding molecules for anti-angiogenesis therapyBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2042US2005176633A1Use of egfr transactivation inhibitors in human cancerFiled 2003·Application pending·0 cites
- 2138US2014093499A1Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf agentsGSCHWIND ANDREAS·Filed 2013·Application pending·0 cites
- 2238US2014093498A1Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf-r agentsGSCHWIND ANDREAS·Filed 2013·Application pending·0 cites
- 2335US2013078247A1Bispecific binding molecules binding to dii4 and ang2GSCHWIND ANDREAS·Filed 2012·Application pending·0 cites
- 2435US2011195494A1Dll4-binging moleculesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Gschwind files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →